TIMI 14 Articles

Angiographic and clinical characteristics associated with the development of Q-wave and non-Q–wave myocardial infarction in the Thrombolysis In Myocardial Infarction (TIMI) 14 trial American Heart Journal 2003 Jul;146:42-7.

Minimal ST-segment deviation: A simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration American Heart Journal 2002 Nov ;144:790-5.

Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction Insights from TIMI 14 and InTIME-II European Heart Journal, 2002 June; 23: 928–933,

Early Coronary Intervention Following Pharmacologic Therapy for Acute Myocardial Infarction (The Combined TIMI 10B–TIMI 14 Experience) American Journal of Cardiology 2001 Oct 15;88:831–836

Early Noninvasive Detection of Failed Epicardial Reperfusion After Fibrinolytic Therapy American Journal of Cardiology 2001 Aug 15 ;88:353–358

Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction A TIMI 14 Substudy Circulation. 2001 May 29;103:2550-2554.

Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial American Heart Journal 2001 April ;141: 592-8.

Impact of Contrast Agent Type (Ionic Versus Nonionic) Used for Coronary Angiography on Angiographic, Electrocardiographic, and Clinical Outcomes Following Thrombolytic Administration in Acute Myocardial Infarction Catheterization Cardiovascular Intervention 2001;53:6–11

Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14 European Heart Journal 2000 Dec ; 21: 1944–1953,

Heart-Type Fatty Acid Binding Protein as a marker of reperfusion after thrombolytic therapy Clinica Chimica Acta 298 (2000) Aug 85 –97

High Levels of Platelet Inhibition With Abciximab Despite Heightened Platelet Activation and Aggregation During Thrombolysis for Acute Myocardial Infarction Results From TIMI (Thrombolysis In Myocardial Infarction) 14 Circulation. 2000 Jun 13 ;101:2690- 2695.

ST-Segment Resolution and Infarct-Related Artery Patency and Flow After Thrombolytic Therapy American Journal of Cardiology 2000 Feb 1;85:299–304

Abciximab Improves Both Epicardial Flow and Myocardial Reperfusion in ST-Elevation Myocardial Infarction Observations from the TIMI 14 Trial  (Circulation. Jan 25 2000;101:239-243.)

Abciximab Facilitates the Rate and Extent of Thrombolysis Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 Trial Circulation. 1999 Jun1;99:2720-2732.